Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
fabrizio.conti@uniroma1.it
Fabrizio Conti
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
fabrizio.conti@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Arthritis in systemic lupus erythematosus. from 2022 international GISEA/OEG symposium
JOURNAL OF CLINICAL MEDICINE
2022
Cultural adaptation and preliminary validation of the qualisex questionnaire for its use in patients with sjögren's syndrome and fibromyalgia in italy
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022
Axial spondyloarthritis: reshape the future—from the “2022 GISEA international symposium”
JOURNAL OF CLINICAL MEDICINE
2022
Science and visual arts: binomial or dichotomy. a pilot study in systemic lupus erythematosus patients
LUPUS
2022
Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in italy. an observatioNal lOngitudinal study of real-life clinical practice) observational longitudinal study
BMC RHEUMATOLOGY
2022
Psychological fragility in an italian cohort of systemic sclerosis patients during covid-19 pandemic category. short communication
OPEN ACCESS RHEUMATOLOGY
2022
Can machine learning models support physicians in systemic lupus erythematosus diagnosis. results from a monocentric cohort
JOINT BONE SPINE
2022
Tofacitinib decreases autophagy of fibroblast-like synoviocytes from rheumatoid arthritis patients
FRONTIERS IN PHARMACOLOGY
2022
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors. results from a monocentric cohort
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2022
“Protenuria in SLE: Is it always lupus?”
LUPUS
2021
Complementary effects of carbamylated and citrullinated ll37 in autoimmunity and inflammation in systemic lupus erythematosus
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2021
Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al
ANNALS OF THE RHEUMATIC DISEASES
2021
Response to to consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis
ANNALS OF THE RHEUMATIC DISEASES
2021
Evaluation of renal resistive index in different autoimmune diseases
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
2021
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts’ Consensus
AUTOIMMUNITY REVIEWS
2021
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA
JOINT BONE SPINE
2021
Genetic diversity of staphylococcus aureus influences disease phenotype of systemic lupus erythematosus
RHEUMATOLOGY
2021
Anti-vimentin/cardiolipin IgA in the antiphospholipid syndrome: a new tool for “seronegative” diagnosis
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
2021
ENDOTHELIAL FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: IMPACT OF CAFFEINE CONSUMPTION ON ENDOTHELIAL PROGENITOR CELLS
Volume 80, Issue Suppl 1
2021
Immune checkpoint inhibitors and pre-existing antinuclear antibodies: the rheumatologist point of view
CLINICAL & TRANSLATIONAL ONCOLOGY
2021
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »
Progetti di Ricerca
MODULATION OF NEURO-IMMUNE INTERACTION THROUGH JAK INHIBITION IN RHEUMATOID ARTHRITIS
Characterization of regulatory T cells in psoriatic arthritis patients: role of type I interferons in restraining cAMP-mediated immune suppression, and implications for metabolic inflammation.
Activation of salivary gland epithelial cells from different subset of patients with primary Sjögren syndrome: towards a personalized medicine
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma